等待開盤 05-20 09:30:00 美东时间
-0.350
-1.68%
今日重点评级关注:Needham:维持Artiva Biotherapeutics"买入"评级,目标价从18美元升至41美元;HC Wainwright & Co.:维持SAB Biotherapeutics"买入"评级,目标价从7美元升至10美元
05-13 11:46
Stifel analyst Daniel Arias initiates coverage on Alamar Biosciences (NASDAQ:ALMR) with a Buy rating and announces Price Target of $28.
05-12 18:46
Alamar Biosciences (NASDAQ:ALMR) reported quarterly losses of $(1.74) per share. The company reported $26.035 million in sales this quarter.
05-08 20:10
伊朗开放霍尔木兹海峡,纳指涨超1.5%录得13连涨!追平1992年以来最长连涨纪录;大型科技股悉数走强,特斯拉涨超3%,苹果涨超2%;稀土概念股CRML大涨超35%>>
04-18 09:07
Alamar Biosciences (ALMR) climbed ~40% on Friday after the commercial-stage proteomics company priced its upsized initial public offering of roughly 11.3M shares to raise approximately $191M in gross ...
04-18 01:25
UPDATE 1-Kailera, Alamar launch US IPOs as biotech listings gather momentum Changes media packaging code to USA-IPO/BIOTECH, adds details on Kailera and Alamar IPOs throughout April 13 (Reuters) - Alamar Biosciences and Kailera Therapeutics kicked off roadshows for their U.S. initial public offering
04-13 19:58